{"title":"MDA/2008/065 - Neurostimulator programmers manufactured by Medtronic – N’Vision® and InterStim iCon® used with InterStim implantable neurostimulator model 3023 for pelvic floor disorders","public_updated_at":"2014-12-17T14:54:31Z","details":{"metadata":{"alert_type":"devices","issued_date":"2008-09-11","medical_specialism":[],"bulk_published":true,"document_type":"medical_safety_alert"},"change_history":[{"id":66839,"note":"First published.","public_timestamp":"2014-12-17T14:54:31Z","edition_id":999355,"created_at":"2017-05-12T10:03:06Z","updated_at":"2017-05-12T10:03:06Z","content_id":"c8e3ace9-3c7c-43b0-8d52-377160bd7dba"}],"body":[{"content_type":"text/html","content":"<p>Issued: 11 September 2008 at 15:30 </p>\n\n<p>Ref: MDA/2008/065  </p>\n\n<p>Action deadlines for the Central Alerting System (CAS)<br />\nDeadline (action underway): 10 October 2008  Deadline (action complete): 11 December 2008  </p>\n\n<h2 id=\"device\">Device</h2>\n<p>Neurostimulator programmers manufactured by Medtronic – N’Vision® and InterStim iCon® used with InterStim implantable neurostimulator model 3023 for pelvic floor disorders.   </p>\n\n<p>Medtronic N’Vision® clinician programmer (fitted with the InterStim B software – 8870 NNB_01 application card) and InterStim iCon® patient programmer (model 3037) when used with InterStim implantable neurostimulator (model 3023) for pelvic floor disorders. </p>\n\n<h2 id=\"problem\">Problem</h2>\n<p>An error in the programmer software (revision NNB_01) may lead to false warnings of a low battery status. There is a risk that pre-existing symptoms may return if the device ceases to function when true low or end of service battery warnings are subsequently ignored.</p>\n\n<p>There are three ways to measure battery status in the model 3023 InterStim neurostimulator:</p>\n\n<ul>\n  <li>using the InterStim iCon patient programmer </li>\n  <li>Automated Measurement feature on N’Vision clinician programmer </li>\n  <li>Therapy Measurement feature on N’Vision clinician programmer.</li>\n</ul>\n\n<p>Medtronic has identified that only the Therapy Measurement feature on the N’Vision programmer is accurate. It is therefore important to interpret all other low battery warnings with caution.</p>\n\n<p>In July 2007 Medtronic issued a Field Safety Notice (FSN) to alert users to the potential for false low battery warnings on the clinician and patient programmers and to advise of an accurate way to assess the battery capacity on the clinician programmer (see Appendix). Clinicians were advised that patients experiencing a low battery warning on their programmer (which were subsequently confirmed as false in clinic) should ignore further low battery warnings. The FSN also advised that new software was in development for both clinician and patient programmers to address the issue.</p>\n\n<p>In July 2008 Medtronic advised the MHRA that the software upgrade was in the approval process and would not be available for implementation for a further few months.</p>\n\n<p>It is possible that some model 3023 InterStim devices are now nearing the end of their life, and so genuine low battery alerts may be ignored (although it should be noted that the end of service (EOS) battery alert on the iCon programmer is valid). This could lead to a device ceasing to function before it can be replaced, and a return of the patient’s pre-existing symptoms.</p>\n\n<h2 id=\"action\">Action</h2>\n<p>Consider the need for in clinic review of battery status for patients who have received multiple low battery alerts on their iCon programmer or if their neurostimulator has been implanted for more than two years. \nConfirm battery status using the N’Vision Therapy Measurement feature, which is a reliable indicator. Do not rely on the N’Vision low battery alert in the Automated Measurement feature to assess battery status. </p>\n\n<h2 id=\"action-by\">Action by</h2>\n<p>All healthcare professionals who are involved in the management of patients with this device.   </p>\n\n<h2 id=\"appendix\">Appendix</h2>\n<p>Manufacturer’s Field Safety Notice of July 2007 (in pdf only).</p>\n\n<h2 id=\"distribution\">Distribution</h2>\n\n<ul>\n  <li>NHS trusts in England - Chief Executives </li>\n  <li>Healthcare Commission (CHAI)  - Headquarters </li>\n  <li>NHS Boards in Scotland - Chief Executives </li>\n</ul>\n\n<p>Please bring this notice to the attention of all who need to know or be aware of it. This may include distribution by:</p>\n\n<p>Trusts to:\nCAS liaison officers for onward distribution to all relevant staff including:</p>\n\n<ul>\n  <li>Clinical governance leads</li>\n  <li>Gynaecology departments</li>\n  <li>Gynaecology lead nurses</li>\n  <li>Gynaecology surgical directors</li>\n  <li>Medical directors</li>\n  <li>Medical physics departments</li>\n  <li>Nursing executive directors</li>\n  <li>Risk managers</li>\n  <li>Urological surgery, directors of</li>\n  <li>Urology departments</li>\n  <li>Urology lead nurses</li>\n</ul>\n\n<p>Healthcare Commission (CHAI) to:\nHeadquarters for onward distribution to:\n* Hospitals in the independent sector\n* Independent treatment centres</p>\n\n<h2 id=\"contacts\">Contacts</h2>\n<p>Details of manufacturer contacts and contacts for technical and clinical aspects. Change of address or removal from address list for Healthcare Commission.</p>\n\n<p>Enquiries to the manufacturer should be addressed to: </p>\n\n<div class=\"address\"><div class=\"adr org fn\"><p>\n\nDr David Dunham\n<br />Regulatory Affairs Manager – UK &amp; Ireland\n<br />Medtronic Limited\n<br />Suite One\n<br />Sherbourne House\n<br />Croxley Business Centre\n<br />Watford, Herts\n<br />WD18 8WW\n<br />Tel: 01923 212 213\n<br />Fax: 01923 241 004\n<br />E-mail: david.dunham@medtronic.com\n<br />\n</p></div></div>\n\n<p>Enquiries to the MHRA should quote reference number 2007/002/001/401/009 and be addressed to:</p>\n\n<p>Technical aspects:</p>\n\n<div class=\"address\"><div class=\"adr org fn\"><p>\n\nMiss Katy Hopkins or Ms Hazel Randall\n<br />Medicines &amp; Healthcare products Regulatory Agency\n<br />Market Towers\n<br />1 Nine Elms Lane\n<br />London\n<br />SW8 5NQ\n<br />Tel: 020 7084 3176 / 3287\n<br />Fax: 020 7084 3106\n<br />E-mail: katy.hopkins@mhra.gsi.gov.uk\n<br />hazel.randall@mhra.gsi.gov.uk\n<br />\n</p></div></div>\n\n<p>Clinical aspects:</p>\n\n<div class=\"address\"><div class=\"adr org fn\"><p>\n\nDr Christopher Brittain\n<br />Medicines &amp; Healthcare products Regulatory Agency\n<br />Market Towers\n<br />1 Nine Elms Lane\n<br />London SW8 5NQ\n<br />Tel: 020 7084 3126\n<br />Fax: 020 7084 3103\n<br />E-mail: christopher.brittain@mhra.gsi.gov.uk\n<br />\n</p></div></div>\n\n<p>Enquiries for Scotland should be directed to:</p>\n\n<div class=\"address\"><div class=\"adr org fn\"><p>\n\nIncident Reporting and Investigation Centre\n<br />Health Facilities Scotland\n<br />NHS National Services Scotland\n<br />Gyle Square\n<br />1 South Gyle Crescent\n<br />Edinburgh\n<br />EH12 9EB\n<br />Tel: 0131 275 7575\n<br />Fax: 0131 314 0722\n<br />E-mail: iric@shs.csa.scot.nhs.uk\n<br />\n</p></div></div>\n\n<p>Change of address or removal from address list for Healthcare Commission:</p>\n\n<div class=\"address\"><div class=\"adr org fn\"><p>\n\nHealthcare Commission\n<br />Finsbury Tower\n<br />103-105 Bunhill Row\n<br />London\n<br />EC1Y 8TG\n<br />Tel: 020 7448 0842\n<br />E-mail: contacts@healthcarecommission.org.uk\n<br />\n</p></div></div>\n\n<h2 id=\"how-to-report-adverse-incidents\">How to report adverse incidents</h2>\n\n<p>Incidents relating to medical devices must be reported to the Medicines and Healthcare products Regulatory Agency (MHRA) as soon as possible.</p>\n\n<p>Further information about reporting incidents; online incident reporting facilities; and downloadable report forms are available from MHRA&rsquo;s website (http://www.mhra.gov.uk).</p>\n\n<p>Alternatively, further information and printed incident report forms are available from:</p>\n\n<div class=\"address\"><div class=\"adr org fn\"><p>\n\nMHRA Adverse Incident Centre\n<br />Medicines and Healthcare products Regulatory Agency\n<br />Market Towers, 1 Nine Elms Lane, London SW8 5NQ\n<br />Telephone 020 7084 3080 or Fax 020 7084 3109\n<br />or e-mail: aic@mhra.gsi.gov.uk\n<br />\n</p></div></div>\n\n<p>(An answerphone service operates outside normal officer hours)</p>\n"},{"content_type":"text/govspeak","content":"Issued: 11 September 2008 at 15:30 \r\n\r\nRef: MDA/2008/065  \r\n \r\n\r\nAction deadlines for the Central Alerting System (CAS)  \r\nDeadline (action underway): 10 October 2008  Deadline (action complete): 11 December 2008  \r\n\r\n## Device\r\nNeurostimulator programmers manufactured by Medtronic – N’Vision® and InterStim iCon® used with InterStim implantable neurostimulator model 3023 for pelvic floor disorders.   \r\n\r\nMedtronic N’Vision® clinician programmer (fitted with the InterStim B software – 8870 NNB_01 application card) and InterStim iCon® patient programmer (model 3037) when used with InterStim implantable neurostimulator (model 3023) for pelvic floor disorders. \r\n\r\n## Problem\r\nAn error in the programmer software (revision NNB_01) may lead to false warnings of a low battery status. There is a risk that pre-existing symptoms may return if the device ceases to function when true low or end of service battery warnings are subsequently ignored.\r\n\r\nThere are three ways to measure battery status in the model 3023 InterStim neurostimulator:\r\n\r\n* using the InterStim iCon patient programmer \r\n* Automated Measurement feature on N’Vision clinician programmer \r\n* Therapy Measurement feature on N’Vision clinician programmer.\r\n\r\nMedtronic has identified that only the Therapy Measurement feature on the N’Vision programmer is accurate. It is therefore important to interpret all other low battery warnings with caution.\r\n\r\nIn July 2007 Medtronic issued a Field Safety Notice (FSN) to alert users to the potential for false low battery warnings on the clinician and patient programmers and to advise of an accurate way to assess the battery capacity on the clinician programmer (see Appendix). Clinicians were advised that patients experiencing a low battery warning on their programmer (which were subsequently confirmed as false in clinic) should ignore further low battery warnings. The FSN also advised that new software was in development for both clinician and patient programmers to address the issue.\r\n\r\nIn July 2008 Medtronic advised the MHRA that the software upgrade was in the approval process and would not be available for implementation for a further few months.\r\n\r\nIt is possible that some model 3023 InterStim devices are now nearing the end of their life, and so genuine low battery alerts may be ignored (although it should be noted that the end of service (EOS) battery alert on the iCon programmer is valid). This could lead to a device ceasing to function before it can be replaced, and a return of the patient’s pre-existing symptoms.\r\n\r\n## Action\r\nConsider the need for in clinic review of battery status for patients who have received multiple low battery alerts on their iCon programmer or if their neurostimulator has been implanted for more than two years. \r\nConfirm battery status using the N’Vision Therapy Measurement feature, which is a reliable indicator. Do not rely on the N’Vision low battery alert in the Automated Measurement feature to assess battery status. \r\n\r\n## Action by\r\nAll healthcare professionals who are involved in the management of patients with this device.   \r\n\r\n## Appendix\r\nManufacturer’s Field Safety Notice of July 2007 (in pdf only).\r\n\r\n## Distribution\r\n\r\n* NHS trusts in England - Chief Executives \r\n* Healthcare Commission (CHAI)  - Headquarters \r\n* NHS Boards in Scotland - Chief Executives \r\n\r\nPlease bring this notice to the attention of all who need to know or be aware of it. This may include distribution by:\r\n\r\nTrusts to:\r\nCAS liaison officers for onward distribution to all relevant staff including:\r\n\r\n* Clinical governance leads\r\n* Gynaecology departments\r\n* Gynaecology lead nurses\r\n* Gynaecology surgical directors\r\n* Medical directors\r\n* Medical physics departments\r\n* Nursing executive directors\r\n* Risk managers\r\n* Urological surgery, directors of\r\n* Urology departments\r\n* Urology lead nurses\r\n\r\nHealthcare Commission (CHAI) to:\r\nHeadquarters for onward distribution to:\r\n* Hospitals in the independent sector\r\n* Independent treatment centres\r\n\r\n## Contacts\r\nDetails of manufacturer contacts and contacts for technical and clinical aspects. Change of address or removal from address list for Healthcare Commission.\r\n \r\n\r\nEnquiries to the manufacturer should be addressed to: \r\n\r\n\r\n$A\r\nDr David Dunham\r\nRegulatory Affairs Manager – UK & Ireland\r\nMedtronic Limited\r\nSuite One\r\nSherbourne House\r\nCroxley Business Centre\r\nWatford, Herts\r\nWD18 8WW\r\nTel: 01923 212 213\r\nFax: 01923 241 004\r\nE-mail: david.dunham@medtronic.com\r\n$A\r\n\r\nEnquiries to the MHRA should quote reference number 2007/002/001/401/009 and be addressed to:\r\n\r\n\r\nTechnical aspects:\r\n\r\n\r\n$A\r\nMiss Katy Hopkins or Ms Hazel Randall\r\nMedicines & Healthcare products Regulatory Agency\r\nMarket Towers\r\n1 Nine Elms Lane\r\nLondon\r\nSW8 5NQ\r\nTel: 020 7084 3176 / 3287\r\nFax: 020 7084 3106\r\nE-mail: katy.hopkins@mhra.gsi.gov.uk\r\nhazel.randall@mhra.gsi.gov.uk\r\n$A\r\n\r\nClinical aspects:\r\n\r\n\r\n$A\r\nDr Christopher Brittain\r\nMedicines & Healthcare products Regulatory Agency\r\nMarket Towers\r\n1 Nine Elms Lane\r\nLondon SW8 5NQ\r\nTel: 020 7084 3126\r\nFax: 020 7084 3103\r\nE-mail: christopher.brittain@mhra.gsi.gov.uk\r\n$A\r\n\r\nEnquiries for Scotland should be directed to:\r\n\r\n\r\n$A\r\nIncident Reporting and Investigation Centre\r\nHealth Facilities Scotland\r\nNHS National Services Scotland\r\nGyle Square\r\n1 South Gyle Crescent\r\nEdinburgh\r\nEH12 9EB\r\nTel: 0131 275 7575\r\nFax: 0131 314 0722\r\nE-mail: iric@shs.csa.scot.nhs.uk\r\n$A\r\n\r\nChange of address or removal from address list for Healthcare Commission:\r\n\r\n\r\n$A\r\nHealthcare Commission\r\nFinsbury Tower\r\n103-105 Bunhill Row\r\nLondon\r\nEC1Y 8TG\r\nTel: 020 7448 0842\r\nE-mail: contacts@healthcarecommission.org.uk\r\n$A\r\n\r\n## How to report adverse incidents\r\n\r\nIncidents relating to medical devices must be reported to the Medicines and Healthcare products Regulatory Agency (MHRA) as soon as possible.\r\n\r\nFurther information about reporting incidents; online incident reporting facilities; and downloadable report forms are available from MHRA's website (http://www.mhra.gov.uk).\r\n\r\nAlternatively, further information and printed incident report forms are available from:\r\n\r\n\r\n$A\r\nMHRA Adverse Incident Centre\r\nMedicines and Healthcare products Regulatory Agency\r\nMarket Towers, 1 Nine Elms Lane, London SW8 5NQ\r\nTelephone 020 7084 3080 or Fax 020 7084 3109\r\nor e-mail: aic@mhra.gsi.gov.uk\r\n$A\r\n\r\n(An answerphone service operates outside normal officer hours)"}],"max_cache_time":10,"temporary_update_type":false,"attachments":[{"content_id":"e0a386d2-bfc5-43ff-8207-59e83b24c5b1","title":"MDA2008065 - Neurostimulator programmers manufactured by Medtronic – N’Vision® and InterStim iCon® used with InterStim implantable neurostimulator model 3023 for pelvic floor disorders ","url":"https://assets.digital.cabinet-office.gov.uk/media/54789902ed915d4c0d000001/MDA2008065.pdf","updated_at":"2014-11-28T15:47:13Z","created_at":"2014-11-28T15:47:14Z","content_type":"application/pdf"}],"headers":[{"text":"Device","level":2,"id":"device"},{"text":"Problem","level":2,"id":"problem"},{"text":"Action","level":2,"id":"action"},{"text":"Action by","level":2,"id":"action-by"},{"text":"Appendix","level":2,"id":"appendix"},{"text":"Distribution","level":2,"id":"distribution"},{"text":"Contacts","level":2,"id":"contacts"},{"text":"How to report adverse incidents","level":2,"id":"how-to-report-adverse-incidents"}]},"routes":[{"path":"/drug-device-alerts/mda-2008-065-neurostimulator-programmers-manufactured-by-medtronic-n-vision-and-interstim-icon-used-with-interstim-implantable-neurostimulator-model-3023-for-pelvic-floor-disorders","type":"exact"}],"redirects":[],"publishing_app":"specialist-publisher","rendering_app":"government-frontend","need_ids":[],"phase":"live","analytics_identifier":null,"document_type":"medical_safety_alert","schema_name":"specialist_document","first_published_at":null,"base_path":"/drug-device-alerts/mda-2008-065-neurostimulator-programmers-manufactured-by-medtronic-n-vision-and-interstim-icon-used-with-interstim-implantable-neurostimulator-model-3023-for-pelvic-floor-disorders","description":"This Medical Device Alert highlights an error in the programmer software (revision NNB_01) which may lead to false warnings of a low battery status.","content_id":"c8e3ace9-3c7c-43b0-8d52-377160bd7dba","locale":"en","expanded_links":{"organisations":[{"analytics_identifier":"EA63","api_path":"/api/content/government/organisations/medicines-and-healthcare-products-regulatory-agency","base_path":"/government/organisations/medicines-and-healthcare-products-regulatory-agency","content_id":"240f72bd-9a4d-4f39-94d9-77235cadde8e","description":null,"document_type":"organisation","locale":"en","public_updated_at":"2015-06-29T14:33:29Z","schema_name":"placeholder","title":"Medicines and Healthcare products Regulatory Agency","withdrawn":false,"details":{"brand":"department-of-health","logo":{"formatted_title":"Medicines &amp; Healthcare products<br/>Regulatory Agency","crest":"single-identity"}},"links":{}}],"finder":[{"analytics_identifier":null,"api_path":"/api/content/drug-device-alerts","base_path":"/drug-device-alerts","content_id":"1e9c0ada-5f7e-43cc-a55f-cc32757edaa3","description":"Find alerts and recalls issued by MHRA","document_type":"finder","locale":"en","public_updated_at":"2017-03-30T10:34:00Z","schema_name":"finder","title":"Alerts and recalls for drugs and medical devices","withdrawn":false,"details":{"document_noun":"alert","filter":{"document_type":"medical_safety_alert"},"format_name":"Medical safety alert","show_summaries":true,"facets":[{"key":"alert_type","name":"Alert type","type":"text","preposition":"for","display_as_result_metadata":true,"filterable":true,"allowed_values":[{"label":"Drug alert","value":"drugs"},{"label":"Medical device alert","value":"devices"},{"label":"Field safety notice","value":"field-safety-notices"},{"label":"Drug alert: company-led","value":"company-led-drugs"}]},{"key":"medical_specialism","name":"Medical specialism","type":"text","preposition":"about","display_as_result_metadata":true,"filterable":true,"allowed_values":[{"label":"Anaesthetics","value":"anaesthetics"},{"label":"Cardiology","value":"cardiology"},{"label":"Care home staff","value":"care-home-staff"},{"label":"Cosmetic surgery","value":"cosmetic-surgery"},{"label":"Critical care","value":"critical-care"},{"label":"Dentistry","value":"dentistry"},{"label":"General practice","value":"general-practice"},{"label":"General surgery","value":"general-surgery"},{"label":"Haematology and oncology","value":"haematology-oncology"},{"label":"Infection prevention","value":"infection-prevention"},{"label":"Obstetrics and gynaecology","value":"obstetrics-gynaecology"},{"label":"Ophthalmology","value":"ophthalmology"},{"label":"Orthopaedics","value":"orthopaedics"},{"label":"Paediatrics","value":"paediatrics"},{"label":"Pathology","value":"pathology"},{"label":"Pharmacy","value":"pharmacy"},{"label":"Physiotherapy and occupational therapy","value":"physiotherapy-occupational-therapy"},{"label":"Radiology","value":"radiology"},{"label":"Renal medicine","value":"renal-medicine"},{"label":"Theatre practitioners","value":"theatre-practitioners"},{"label":"Urology","value":"urology"},{"label":"Vascular and cardiac surgery","value":"vascular-cardiac-surgery"}]},{"key":"issued_date","name":"Issued","short_name":"Issued","type":"date","preposition":"issued","display_as_result_metadata":true,"filterable":true}],"default_documents_per_page":50},"links":{}}]},"format":"specialist_document","navigation_document_supertype":"other","user_journey_document_supertype":"thing","email_document_supertype":"other","government_document_supertype":"other","payload_version":0}